Antibody response to pneumococcal vaccine in patients with trisomy-21 (Down's syndrome)
Nurmi, T.; Leinonen, M.; Häivä, V.M.; Tiilikainen, A.; Kouvalainen, K.
Clinical and Experimental Immunology 48(2): 485-490
1982
ISSN/ISBN: 0009-9104 PMID: 6213331 Document Number: 189633
The antibody response to pneumococcal vaccine was lower in adults with trisomy-21 (Down's syndrome) than in controls. Males gave lower response than females, significantly so among the 21-trisomic patients. The antibody response to different polysaccharides differed between the groups.
Document emailed within 1 workday
Related Documents
Doherty, M.J.; Greenstone, M.A.; Meigh, R. 1997: Pneumococcal vaccine campaign based in general practice. Small audit showed that only 14% of patients were offered pneumococcal vaccine Bmj 315(7111): 816Lue, C.; Tarkowski, A.; Mestecky, J. 1988: Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies Journal of Immunology 140(11): 3793-3800
Lue, C.; Tarkowski, A.; Mestecky, J. 1988: Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies Journal of Immunology 140(11): 3793-3800
Sabin, A.B.; Flores Arechiga, A.; Fernández de Castro, J.; Albrecht, P.; Sever, J.L.; Shekarchi, I. 1984: Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response JAMA 251(18): 2363-2371
Epstein, C.J.; Weil, J.; Epstein, L.B. 1987: Abnormalities in the interferon response and immune systems in down syndrome: studies in human trisomy 21 and mouse trisomy 16 Progress in Clinical and Biological Research 246: 191-208
Vyse, A.; Campling, J.; Czudek, C.; Ellsbury, G.; Slack, M. 2020: The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in development Vaccine 38(51): 8068-8070
1996: Belgian consensus on pneumococcal vaccine. Working Party on Pneumococcal Vaccine Acta Clinica Belgica 51(5): 350-356
Measel, J.W. 1982: The effect of the lymphatic pump on the immune response: I. Preliminary studies on the antibody response to pneumococcal polysaccharide assayed by bacterial agglutination and passive hemagglutination Journal of the American Osteopathic Association 82(1): 28-31
Vernacchio, L.; Neufeld, E.J.; Macdonald, K.; Kurth, S.; Murakami, S.; Hohne, C.; King, M.; Molrine, D. 1998: Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease Journal of Pediatrics 133(2): 275-278
Migneco, G.; Tripi, S.; Navetta, A.; La Ferla, A.; Vaccaro, F. 1990: Serum zinc concentration and antibody response to hepatitis B vaccine in hemodialysis patients Minerva Medica 81(1-2): 19-21
Poldre, P.A. 1989: Splenic hypofunction in systemic lupus erythematosus: response to pneumococcal vaccine Journal of Rheumatology 16(8): 1130-1131
Epstein, M.M.; Gruskay, F. 1995: Selective deficiency in pneumococcal antibody response in children with recurrent infections Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 75(2): 125-131
Baker, P.J.; Amsbaugh, D.F.; Prescott, B.; Stashak, P.W. 1976: Analysis of genes governing the antibody response to type IIi pneumococcal polysaccharide (SSS-III) Folia Biologica 22(6): 407-408
Yoshida, F.T.; Takahashi, C.; Mercadante, L.A.; Camargo, I.F.; Schatzmayr, H.G. 1988: Antibody response to heat-inactivated hepatitis B vaccine (CLB-3 micrograms) in hemodialysis patients and occupational risk personnel: a one year follow-up Revista do Instituto de Medicina Tropical de Sao Paulo 30(1): 11-16
Sklenar, I.; Dürig, M.; Lydick, E.; Erb, P.; Harder, F. 1985: Antibody response to pneumococcal polysaccharide antigens following splenectomy and replantation of autologous splenic tissue Aktuelle Probleme in Chirurgie und Orthopadie 30: 107-112
Baker, P.J.; Stashak, P.W.; Amsbaugh, D.F.; Prescott, B. 1974: Regulation of the antibody response to type 3 pneumococcal polysaccharide. II. Mode of action of thymic-derived suppressor cells Journal of Immunology 112(1): 404-409
Fowlkes, A.; Witte, D.; Beeler, J.; Audet, S.; Garcia, P.; Curns, A.; Yang, C.; Fudzulani, R.; Broadhead, R.; Bellini, W.J.; Cutts, F.; Helfand, R.F. 2011: Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi Journal of Infectious Diseases 204(Suppl 1): S149-S157
Aker, M.; Amitai, I.; Hass, H. 1983: Failure of pneumococcal vaccine to prevent pneumococcal meningitis Harefuah 105(7): 164
Brandstetter, R.D.; Kaplowitz, I.; Pugliese, A.; Andresen, A.; Phillips, E. 1991: Fatal pneumococcal infection: another plea for the pneumococcal vaccine New York State Journal of Medicine 91(1): 36
Austrian, R. 1988: Correction: pneumococcal vaccine and pneumococcal pneumonia Annals of Internal Medicine 109(9): 762-763